Bictegravir-emtrictabine-tenofovir alafenamide in combination with oxcarbazepine in a person living with HIV and viral load suppression
We describe a case of a person living with HIV (PWH) with concurrent use of bictegravir and oxcarbazepine. Concomitant use of these pharmacotherapy regimens is considered contraindicated. A review of the literature, therapeutic bictegravir drug concentration monitoring and viral load evaluations allowed the continued current pharmacotherapy prescription of these medications.
Authors
- Patricia Pecora Fulco (ORCID: https://orcid.org/0000-0002-6124-7205)
- Megan Gray (ORCID: https://orcid.org/0000-0002-9172-6821)
Institutions
- Virginia Commonwealth University (US)
Publication Details
- Journal
- International Journal of STD & AIDS
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1177/09564624251335146
- Citations
- 1
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.40